Search Results - "Rideout, Hardy J"

Refine Results
  1. 1

    Pathological roles of α-synuclein in neurological disorders by Vekrellis, Kostas, PhD, Xilouri, Maria, PhD, Emmanouilidou, Evangelia, PhD, Rideout, Hardy J, PhD, Stefanis, Leonidas, Dr

    Published in Lancet neurology (01-11-2011)
    “…Summary Substantial genetic, neuropathological, and biochemical evidence implicates the presynaptic neuronal protein α-synuclein in Parkinson's disease and…”
    Get full text
    Journal Article
  2. 2

    The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease by Rideout, Hardy J., Stefanis, Leonidas

    Published in Neurochemical research (01-03-2014)
    “…Leucine-rich repeat kinase 2 (LRRK2) is a large, widely expressed protein of largely unknown function. Mutations in the gene encoding LRRK2 have been linked to…”
    Get full text
    Journal Article
  3. 3

    LRRK2 Parkinson disease mutations enhance its microtubule association by Kett, Lauren R., Boassa, Daniela, Ho, Cherry Cheng-Ying, Rideout, Hardy J., Hu, Junru, Terada, Masako, Ellisman, Mark, Dauer, William T.

    Published in Human molecular genetics (15-02-2012)
    “…Dominant missense mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic causes of Parkinson disease (PD) and genome-wide association…”
    Get full text
    Journal Article
  4. 4

    A motif within the armadillo repeat of Parkinson’s-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway by Antoniou, Nasia, Vlachakis, Dimitrios, Memou, Anna, Leandrou, Emmanouela, Valkimadi, Polytimi-Eleni, Melachroinou, Katerina, Re, Diane B., Przedborski, Serge, Dauer, William T., Stefanis, Leonidas, Rideout, Hardy J.

    Published in Scientific reports (22-02-2018)
    “…In experimental models, both in vivo and cellular, over-expression of Parkinson’s linked mutant leucine-rich repeat kinase 2 (LRRK2) is sufficient to induce…”
    Get full text
    Journal Article
  5. 5

    The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson’s Disease by Rideout, Hardy J., Chartier-Harlin, Marie-Christine, Fell, Matthew J., Hirst, Warren D., Huntwork-Rodriguez, Sarah, Leyns, Cheryl E. G., Mabrouk, Omar S., Taymans, Jean-Marc

    Published in Frontiers in neuroscience (18-08-2020)
    “…Evidence is mounting that LRRK2 activity, particularly its kinase activity, is elevated in multiple forms of Parkinson’s disease, both idiopathic as well as…”
    Get full text
    Journal Article
  6. 6

    Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations by Melachroinou, Katerina, Leandrou, Emmanouela, Valkimadi, Polytimi-Eleni, Memou, Anna, Hadjigeorgiou, Georgios, Stefanis, Leonidas, Rideout, Hardy J

    Published in PloS one (10-11-2016)
    “…Despite the plethora of sequence variants in LRRK2, only a few clearly segregate with PD. Even within this group of pathogenic mutations, the phenotypic…”
    Get full text
    Journal Article
  7. 7

    The WD40 domain is required for LRRK2 neurotoxicity by Jorgensen, Nathan D, Peng, Yong, Ho, Cherry C-Y, Rideout, Hardy J, Petrey, Donald, Liu, Peng, Dauer, William T

    Published in PloS one (24-12-2009)
    “…Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson disease (PD). LRRK2 contains an "enzymatic core" composed of…”
    Get full text
    Journal Article
  8. 8

    The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease by Polissidis, Alexia, Petropoulou-Vathi, Lilian, Nakos-Bimpos, Modestos, Rideout, Hardy J

    Published in Biomolecules (Basel, Switzerland) (16-06-2020)
    “…Biomarkers and disease-modifying therapies are both urgent unmet medical needs in the treatment of Parkinson's disease (PD) and must be developed concurrently…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Neuronal death signaling pathways triggered by mutant LRRK2 by Rideout, Hardy J

    Published in Biochemical Society transactions (08-02-2017)
    “…Autosomal dominantly inherited mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease…”
    Get more information
    Journal Article
  12. 12

    Targeted disruption of neuronal 19S proteasome subunits induces the formation of ubiquitinated inclusions in the absence of cell death by Droggiti, Anna, Ho, Cherry Chen‐Ying, Stefanis, Leonidas, Dauer, William T., Rideout, Hardy J.

    Published in Journal of neurochemistry (01-11-2011)
    “…J. Neurochem. (2011) 119, 630–643. Proteasome‐mediated proteolysis is a major protein degradation mechanism in cells and its dysfunction has been implicated in…”
    Get full text
    Journal Article
  13. 13

    Defining (and blocking) neuronal death in Parkinson’s disease: Does it matter what we call it? by Memou, Anna, Dimitrakopoulos, Lampros, Kedariti, Maria, Kentros, Michalis, Lamprou, Andriana, Petropoulou-Vathi, Lilian, Valkimadi, Polytimi-Eleni, Rideout, Hardy J.

    Published in Brain research (15-11-2021)
    “…•Neuronal loss in Parkinson’s disease can take multiple forms.•Evidence of apoptotic, necroptotic, and pyroptotic signaling exists in PD.•The role of the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway by Lang‐Rollin, Isabelle, Vekrellis, Konstantinos, Wang, Qiaohong, Rideout, Hardy J., Stefanis, Leonidas

    Published in Journal of neurochemistry (01-09-2004)
    “…Proteasomal dysfunction may play a role in a number of neurodegenerative conditions, and in particular Parkinson's disease (PD) and related Lewy body (LB)…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration by Ho, Cherry Cheng-Ying, Rideout, Hardy J, Ribe, Elena, Troy, Carol M, Dauer, William T

    Published in The Journal of neuroscience (28-01-2009)
    “…Neurodegenerative illnesses such as Parkinson and Alzheimer disease are an increasingly prevalent problem in aging societies, yet no therapies exist that…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Involvement of macroautophagy in the dissolution of neuronal inclusions by Rideout, Hardy J., Lang-Rollin, Isabelle, Stefanis, Leonidas

    “…Ubiquitinated inclusions are a common feature of many neurodegenerative conditions. We have proposed that, at least in part, such inclusions may be formed due…”
    Get full text
    Journal Article
  20. 20

    Synuclein‐1 is selectively up‐regulated in response to nerve growth factor treatment in PC12 cells by Stefanis, Leonidas, Kholodilov, Nikolai, Rideout, Hardy J., Burke, Robert E., Greene, Lloyd A.

    Published in Journal of neurochemistry (01-02-2001)
    “…Mutations in the α‐synuclein gene have recently been identified in families with inherited Parkinson's disease and the protein product of this gene is a…”
    Get full text
    Journal Article